The emergence of AI and biosensors offers a chance to address inefficiencies in drug development.

A large-scale analysis of millions of cancer studies has uncovered patterns suggesting that a significant portion of the literature may not be as reliable as it appears.

A new AI foundation model from Mass General Brigham may be capable of analyzing brain MRI datasets and predict various ...

Mass General Brigham investigators have developed a robust new artificial intelligence (AI) foundation model that is capable ...

Rutgers Develops New Tool for Examining Cancer Genomic Data that Could Improve Treatment When scientists sequence tumor DNA, ...

Swedish study of 100,000 women found higher rate of early detection, suggesting potential to support radiologists The use of artificial intelligence in breast cancer screening reduces the rate of a ...

In the evolving landscape of oncology, skin cancer diagnosis stands out as a domain where the synergy between AI and multimodal imaging is rapidly changing ...

Radiation oncology is being rapidly reshaped by advances in imaging, artificial intelligence, and our understanding of the tumor microenvironment. Over the ...

Prospective monitoring of prostate specific membrane antigen–positive biochemically recurrent prostate cancer (PSMA+ BCR): Preliminary data from 6-month PSMA follow-up.